Sr. Vice President, R&D of Talis Biomedical Corp (NASDAQ:TLIS), Ramakrishnan Ramesh, buys 1,000 shares worth $16,000

According to Talis Biomedical Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 06:16 PM, company Sr. Vice President, R&D, Ramakrishnan Ramesh disclosed buying 1,000 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $16,000 in total. As of Feb 17, Ramakrishnan Ramesh now owns 1,000 shares in total worth about $22,250.0.

For the last few recent trades made by Talis Biomedical Corp (NASDAQ:TLIS) Sr. Vice President, R&D, Ramakrishnan Ramesh, we have the following information:

    Posted by on Friday February 19 2021, 10:44 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

    Comments are closed

    Featured Press Releases

    Log in